Page last updated: 2024-09-03

imatinib mesylate and Pituitary Neoplasms

imatinib mesylate has been researched along with Pituitary Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Lin, Y; Meng, L; Qu, X; Wang, W; Yang, J	1

Other Studies

1 other study(ies) available for imatinib mesylate and Pituitary Neoplasms

Article	Year
Effects of Imatinib Combined With Everolimus on Mouse Pituitary Tumor Cell AtT-20. Alternative therapies in health and medicine, 2023, Volume: 29, Issue:1 Topics: Adrenocorticotropic Hormone; Animals; Apoptosis; Caspase 3; Cell Line, Tumor; Cell Proliferation; Cyclin E; Everolimus; Imatinib Mesylate; Mice; Pituitary Neoplasms; Pro-Opiomelanocortin; Proto-Oncogene Proteins c-akt; RNA, Messenger; Tumor Suppressor Protein p53	2023

Article

Year

Effects of Imatinib Combined With Everolimus on Mouse Pituitary Tumor Cell AtT-20.

Alternative therapies in health and medicine, 2023, Volume: 29, Issue:1

Topics: Adrenocorticotropic Hormone; Animals; Apoptosis; Caspase 3; Cell Line, Tumor; Cell Proliferation; Cyclin E; Everolimus; Imatinib Mesylate; Mice; Pituitary Neoplasms; Pro-Opiomelanocortin; Proto-Oncogene Proteins c-akt; RNA, Messenger; Tumor Suppressor Protein p53

2023